D-二聚体、纤维蛋白原在肺部良性非栓塞性疾病的临床意义被引量：1

Clinical significance of D-dimer, fibrinogen in non-embolic benign lung diseases

导出

摘要 D-二聚体和纤维蛋白原作为机体高凝状态和继发性纤溶亢进的特异性指标之一，临床上应用广泛。本文探讨在肺部良性非栓塞性疾病患者检测血浆D-二聚体、纤维蛋白原水平的临床价值。在肺部良性非栓塞性疾病，血浆口二聚体、纤维蛋白原的水平升高，临床上检测其水平有利于了解机体凝血和纤溶状态，有利于评价疾病的严重程度及预后。 D-dimer and fibrinogen as the specific indicator of activated coagulation and fibrinolytic state,is widely applied in clinic. This paper investigates the clinical value of plasma D dimer, fibrinogen level in patients with non embolic benign lung diseases. In non-embolic benign lung diseases, the levels of plasma D-dimer, fibrinogen are elevated. The detection of the levels of plasma D-dimer, fibrinogen is helpful for understanding the condition ot＂ blood coagulation and fibrinolysis and assessing disease severity and prognosis.

作者程彬彬康健

机构地区中国医科大学附属第一医院呼吸疾病研究所

出处《国际呼吸杂志》 2013年第22期1754-1757,共4页 International Journal of Respiration

关键词 D-二聚体纤维蛋白原慢性阻塞性肺疾病肺炎肺结核支气管哮喘 D-dimer Fibrinogen Chronic obstructive pulmonary disease Pneumonia Tuberculosis Bronchial asthma

分类号 R446.6 [医药卫生—诊断学]

引文网络
相关文献

参考文献37

1Kline JA, Runyon MS, Webb WB,et aI. Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest,2006,129:1417-1423.
2Wada M, Iizuka M, Iwadate Y,et al. Effectiveness of deep vein thrombosis screening on admission toa rehabilitation hospital: a prospective study in 1043 consecutive patients. Thromb Res, 2013, 31 : 487-492.
3Malato A, Saccullo G, Iorio thrombosis and D-dimer for A, et al. Residual vein optimizing duration of anticoagulation in idiopathic deep vein thrombosis Pharm Des, 2010,16 : 3483-3486.
4Galipienzo J, Garcia de Tena J, Flores J,et al. Effectiveness of a diagnostic algorithm combining clinical probability, D- dimer testing, and computed tomography in patients with suspected pulmonary embolism in an emergency department. Rom J Intern Med,2012,50:195-202.
5Komurcuoglu B, Ulusoy S, Gayaf M, et al. Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori, 2011, 97:743-748.
6Kim SY, Kim JE, Kim HK,et al. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis. Blood Coagul Fibrinolysis, 2013,24 : 150- 156.
7Pawlus J, HoIub M, Kozuch M, et al, Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course o{ coronary disease. Int J Lab Hematol,2010,32:320-328.
8朱元珏.特发性间质性肺炎的诊断治疗变迁[J].实用诊断与治疗杂志,2006,20(3):157-160. 被引量：7
9姜正华,吕元文,朱慕云,朱湘平,丁平,汤艳.慢性阻塞性肺疾病患者血气分析与血浆纤维蛋白原的相关性研究[J].实用诊断与治疗杂志,2006,20(1):13-14. 被引量：38
10Gan WQ, Man SF, Senthilselvan A, et aI. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax, 2004,59 : 574-580.